Kimberly-Clark (NYSE:KMB) Price Target Increased to $138.00 by Analysts at UBS Group

Kimberly-Clark (NYSE:KMBGet Free Report) had its price target hoisted by research analysts at UBS Group from $135.00 to $138.00 in a research note issued on Wednesday, Benzinga reports. The firm presently has a “neutral” rating on the stock. UBS Group’s price target suggests a potential upside of 0.54% from the company’s current price.

A number of other equities research analysts also recently weighed in on KMB. The Goldman Sachs Group lifted their price target on shares of Kimberly-Clark from $135.00 to $152.00 and gave the stock a “buy” rating in a research note on Wednesday. Barclays lifted their price objective on Kimberly-Clark from $124.00 to $132.00 and gave the company an “equal weight” rating in a report on Friday, April 12th. Piper Sandler lifted their price objective on Kimberly-Clark from $145.00 to $152.00 and gave the company an “overweight” rating in a report on Thursday, March 28th. JPMorgan Chase & Co. lifted their price target on Kimberly-Clark from $115.00 to $123.00 and gave the company an “underweight” rating in a report on Wednesday. Finally, HSBC lifted their price target on Kimberly-Clark from $134.00 to $146.00 and gave the company a “hold” rating in a report on Thursday, March 28th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $133.71.

Read Our Latest Stock Analysis on Kimberly-Clark

Kimberly-Clark Stock Performance

Shares of Kimberly-Clark stock traded up $1.22 during midday trading on Wednesday, hitting $137.26. The company had a trading volume of 1,322,639 shares, compared to its average volume of 2,192,435. The business’s 50 day simple moving average is $124.78 and its two-hundred day simple moving average is $122.55. The stock has a market cap of $46.24 billion, a PE ratio of 26.38, a P/E/G ratio of 3.83 and a beta of 0.40. The company has a debt-to-equity ratio of 6.94, a current ratio of 0.82 and a quick ratio of 0.54. Kimberly-Clark has a 1-year low of $116.32 and a 1-year high of $147.87.

Kimberly-Clark (NYSE:KMBGet Free Report) last announced its quarterly earnings data on Tuesday, April 23rd. The company reported $2.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.61 by $0.40. The business had revenue of $5.15 billion for the quarter, compared to the consensus estimate of $5.08 billion. Kimberly-Clark had a net margin of 8.63% and a return on equity of 260.47%. Kimberly-Clark’s quarterly revenue was down .9% on a year-over-year basis. During the same quarter last year, the company posted $1.67 earnings per share. As a group, equities analysts predict that Kimberly-Clark will post 6.84 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Tristram Wilkinson sold 3,720 shares of Kimberly-Clark stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $121.00, for a total value of $450,120.00. Following the sale, the insider now directly owns 17,229 shares in the company, valued at $2,084,709. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, insider Tristram Wilkinson sold 3,720 shares of Kimberly-Clark stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $121.00, for a total value of $450,120.00. Following the sale, the insider now directly owns 17,229 shares in the company, valued at $2,084,709. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Mark T. Smucker bought 827 shares of the stock in a transaction that occurred on Monday, January 29th. The shares were purchased at an average price of $120.98 per share, for a total transaction of $100,050.46. Following the completion of the acquisition, the director now owns 827 shares of the company’s stock, valued at approximately $100,050.46. The disclosure for this purchase can be found here. Corporate insiders own 0.62% of the company’s stock.

Hedge Funds Weigh In On Kimberly-Clark

A number of institutional investors have recently added to or reduced their stakes in the company. Rise Advisors LLC boosted its position in Kimberly-Clark by 926.3% during the first quarter. Rise Advisors LLC now owns 195 shares of the company’s stock worth $25,000 after purchasing an additional 176 shares during the period. Accordant Advisory Group Inc bought a new position in Kimberly-Clark during the first quarter worth $27,000. Cranbrook Wealth Management LLC boosted its position in Kimberly-Clark by 90.9% during the fourth quarter. Cranbrook Wealth Management LLC now owns 210 shares of the company’s stock worth $26,000 after purchasing an additional 100 shares during the period. OFI Invest Asset Management bought a new position in Kimberly-Clark during the third quarter worth $25,000. Finally, Centerpoint Advisors LLC boosted its position in Kimberly-Clark by 175.0% during the third quarter. Centerpoint Advisors LLC now owns 275 shares of the company’s stock worth $33,000 after purchasing an additional 175 shares during the period. 76.29% of the stock is currently owned by institutional investors and hedge funds.

Kimberly-Clark Company Profile

(Get Free Report)

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.

Read More

Analyst Recommendations for Kimberly-Clark (NYSE:KMB)

Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.